ILF With/Without Cisplatin for Advanced Gastric Cancer
Status:
Unknown status
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
To compare the combination of irinotecan, leucovorin and 5-FU (ILF) with ILF plus cisplatin
(PILF) as first-line chemotherapy in patients with measurable metastatic gastric cancer.